KCNJ9
G protein-activated inward rectifier potassium channel 3
Also known as: GIRK3, KCNJ9_HUMAN, Kir3.3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92806
- Gene
- KCNJ9
- Ensembl
- ENSG00000162728
- Chromosome
- 1
- Canonical length
- 393 aa
- Protein class
- Predicted membrane proteins, Transporters, Voltage-gated ion channels
OverviewNCBI Gene
Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins. It associates with another G-protein-activated potassium channel to form a heteromultimeric pore-forming complex. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
393 residues, UniProt reviewed canonical sequence.
>Q92806|KCNJ9
1 MAQENAAFSP GQEEPPRRRG RQRYVEKDGR CNVQQGNVRE TYRYLTDLFT TLVDLQWRLS
61 LLFFVLAYAL TWLFFGAIWW LIAYGRGDLE HLEDTAWTPC VNNLNGFVAA FLFSIETETT
121 IGYGHRVITD QCPEGIVLLL LQAILGSMVN AFMVGCMFVK ISQPNKRAAT LVFSSHAVVS
181 LRDGRLCLMF RVGDLRSSHI VEASIRAKLI RSRQTLEGEF IPLHQTDLSV GFDTGDDRLF
241 LVSPLVISHE IDAASPFWEA SRRALERDDF EIVVILEGMV EATGMTCQAR SSYLVDEVLW
301 GHRFTSVLTL EDGFYEVDYA SFHETFEVPT PSCSARELAE AAARLDAHLY WSIPSRLDEK
361 VEEEGAGEGA GGEAGADKEQ NGCLPPPESE SKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNJ9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 69 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 69 nTPM
- cerebral cortex: 59 nTPM
- midbrain: 45 nTPM
- hippocampal formation: 42 nTPM
- amygdala: 35 nTPM
- basal ganglia: 35 nTPM
Single-cell type
- brain excitatory neurons: 22 nCPM
- brain inhibitory neurons: 14 nCPM
- retinal amacrine cells: 13 nCPM
- adrenal medulla cells: 11 nCPM
- oligodendrocytes: 9.8 nCPM
- retinal bipolar cells: 9.8 nCPM
Immune cell
- MAIT T-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebellum: 98 nTPM
- white matter: 89 nTPM
- thalamus: 86 nTPM
- cerebral cortex: 86 nTPM
- amygdala: 79 nTPM
- basal ganglia: 68 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.62
- gnomAD pLI
- 0.3
- gnomAD missense Z
- 4.22
- DepMap mean gene effect
- -0.28
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- potassium ion import across plasma membrane
- regulation of monoatomic ion transmembrane transport
- regulation of presynaptic membrane potential
Molecular functions
- G-protein activated inward rectifier potassium channel activity
- inward rectifier potassium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Potassium channel, inwardly rectifying, Kir, cytoplasmic
- Immunoglobulin E-set
- Potassium channel, inwardly rectifying, Kir
- Potassium channel, inwardly rectifying, transmembrane domain
- Inward rectifier potassium channel, C-terminal
- Inward rectifier potassium channel transmembrane domain
- Inward rectifier potassium channel C-terminal domain
- Potassium channel, inwardly rectifying, Kir3.3
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNJ9 as an antibody target. Whether an autoantibody or antibody against KCNJ9 could matter depends on whether native KCNJ9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNJ9 is annotated at the cell surface, where native KCNJ9 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNJ9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...